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It is a great honor to address the Ninth Annual 
Meeting o f  American Venous Forum. This meeting 
represents the best of American vascular surgeons 
with a special interest in venous disorders. Disease of 
the veins not only has long historical interest but also 
was the dominant feature of  the beginning meetings 
of the Society for Vascular Surgery. Surgery of the 
venous system was discussed in those first addresses 
given by Presidents Ochsner, 1 Allen, 2 and Veal. s As 
arterial surgery flourished, interest in venous disease 
by vascular surgeons began to fade. At present, the 
veins get no respect, despite the fact that the venous 
system contains the greatest part of the blood vol- 
ume in human beings. 
I am honored to be part of the mission of the 
American Venous Forum to restore interest in ve- 
nous disorders to vascular surgeons. I completed my 
surgical residency at Cook County Hospital in June 
1967 and went to St. Mary's Hospital in London to 
begin vascular training. Little did I know then that I 
would be involved in this specialty for 30 years. As I 
stand here today in 1997, it is interesting to reflect 
over the period of my own experience and to con- 
sider how much the diagnosis and treatment of ve- 
nous disorders has changed in that time and what 
needs to change in the future. Because history is 
important o our future, I would also like to recall 
some of the historical andmarks of  this largely ig- 
nored vascular problem. 
Varicose veins are an ancient disease, and there 
were references to varicose veins in the early Egyptian 
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and Greek writings. In fact, a votive tablet from the 
National Museum in Athens illustrating aman hold- 
ing a huge leg with a varicose vein is a frequent 
feature in many historical writings of venous disease. 
My first exposure to venous disorders was varicose 
veins. In 1967, treatment of  varicose veins by sclero- 
therapy was common in the British Isles. The intro- 
duction of  injection treatment coincided with the 
development of  the syringe by a Frenchman, Mon- 
sieur Pravaz of Lyons School, France, in 1851.4 Soon 
thereafter, in 1853, Chassaignac from Saint Antoine 
Hospital of Paris suggested the obliteration of  vari- 
cose veins by injection of perchloride of iron. s So- 
dium morrhuate was introduced in 1931 and was 
extensively used in the United States during the next 
two decades. 6 Although modern days have seen bet- 
ter chemicals for sclerosing therapy, treatment of this 
disorder has evolved into the use of high technology 
such as laser, high-intensity pulsed light, or duplex 
ultrasound-guided sclerotherapy. 7 How good these 
techniques are will never be answered scientifically. 
One fact, however, is true: abuse of  treatment of 
varicose veins is common, and a business approach 
has been adopted by entrepreneur physicians to fran- 
chise for-profit-only vein clinics across the United 
States. 
Vein stripping is probably one of  the most com- 
monly performed surgical procedures. Historical re- 
view of the surgical treatment of varicose veins has 
been well written in detail by Laufman, s Ochsner 
and Mahorner, 9 and Scott. 1° In 1833, Davat at- 
tempted to eliminate the varicose veins by percutane- 
ous ligation (Fig. 1).11 Ligation and saphenous vein 
stripping was first suggested by Madelung 12 in 1844. 
Trendelenburg's operation, which he introduced in 
1880,13 was the forerunner of modern surgery for 
varicose veins. It consisted of  double ligation and 
division of the long saphenous vein below the saphe- 
nofemoral junction. Instrumentation to facilitate re- 
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Fig. 1. Percutaneous ligation of varicose veins byDavat. (After Davat: Du traitement curatif 
des varices. J d conn reed Prat, 1837;5:68,102. Reprinted with permission from Ochsner A, 
Mahorner H. Varicose veins. St. Louis: C. V. Mosby Co., 1939:20.) 
moval of the saphenous vein began in 1905 with 
I(eller, 14 who described removal of segments of vein 
by passing awire through the lumen of the vein (Fig. 
2). This is followed by the external vein stripper 
designed by Mayo in 1904.15 Shortly thereafter, 
Babcock suggested a modification of the Keller 
method and introduced the acorn-tipped intralumi- 
nal stripper, which bears a strong resemblance to the 
modern disposable plastic stripper. 16 As early as 
I904, Tave117 and, in 1916, Homans 18 called atten- 
tion to the advisability of ligation of the long saphe- 
nous vein high above any of its collaterals to prevent 
recurrence. This dictum still holds true in modern 
day varicose vein surgery. Unfortunately, treatment 
of varicose veins is often delegated to the most junior 
staff who have mediocre knowledge of the disease. 
The recurrence rate is high if the initial procedure is
not conducted properly. Controversy continues 
about saving the long saphenous in the thigh, but 
evidence isgrowing that stripping from groin to knee 
level gives better esults than simple flush ligation of 
the saphenofemoral junction alone. 19,2° Recently, 
neovascularization at the groin has been accepted as 
a major cause of recurrent connections between the 
femoral vein and the retained long saphenous vein. 21 
As a result of this observation, some surgeons have 
suggested ligation of not only the primary tributaries 
of the saphenofemoral junction but also tributaries 
that open directly into the femoral vein. 22,23 This 
extended groin figation combined with long saphe- 
nous vein stripping prevents recurrent varicosities. 
The argument o save the saphenous vein in the 
thigh for future coronary bypass grafting is not valid 
because most cardiac surgeons would not like to use 
a varicose or dilated thigh segment of the saphenous 
vein as a conduit for coronary artery bypass grafting. 
In modern days, most vein stripping procedures are 
done on outpatient basis. Interestingly, as early as 
1930, Geza de Takats advocated vein ligation as an 
ambulatory procedure for these patients. 24 The role 
of the short saphenous vein has been emphasized by 
Hobbs, 25 as its incompetence is often overlooked. 
He also called attention to the surgical significance of 
gastrocnemius vein incompetence, the !east-known 
clinical entity to American vascular surgeons.26 Vari- 
cose veins are not always a benign disease; we have 
encountered fatal hemorrhage in these patients. 27 
Varicose veins are common, and yet we knew very 
little about the epidemiologic variables of varicose 
veins in America. Reports from abroad indicate that 
female sex, increased age, pregnancy, geographic 
site, and race are risk factors. 28,29 Also, the pathogen- 
esis of this condition remains poorly understood. A 
familial tendency is common, and the development 
of varicose veins is eventually based on primary val- 
vular insufficiency of the major saphenous trunk, in- 
competence ofthe perforating veins, and venous wall 
weakness. Recently, progesterone r ceptor, elastase, 
and lysosomal enzymes have been implicated as con- 
tributing factors in the formation of varicose 
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veins. 3°-32 Also, venous wall weakness as a result of a 
significant reduction of clastin content of varicose 
veins has been reported by Gandhi and colleagues. 33 
The fibfinolytic potential of the venous system is 
currently an area of research interest. Increased fi- 
brinolytic activity in varicose veins has been report- 
ed. 34 We have studied tissue-type plasminogen acti- 
vator (tPA) and urokinase-type plasminogen 
activator (uPA) in normal and varicose veins. Levels 
of uPA in the varicose long saphenous v~eins were 
significantly higher than in normal veins at both the 
groin and anlde positions, which suggests a role for 
uPA in the pathogenesis of varicose veins. 35 Further 
study using molecular biologic techniques i  needed 
to understand the pathogenesis of varicose veins. 
Perhaps one of the significant developments in 
the field of vascular surgery in the late 1960s was 
noninvasive technology. As a research fellow, my 
primary assignment was to study limb blood flow in 
patients with occlusive arterial disease using strain- 
gauge plethysmography. In 1967, the Doppler ultra- 
sound technique was just being introduced for clini- 
cal use. For the first time, we were able to listen to 
the blood flow of a major vein. Further efinement of
technology has made possible the detection of direc- 
tion of blood flow, recording of blood flow velocity 
waveforms, and analysis of frequency spectrum. The 
development of duplex scanning with the ability to 
image a vessel and to record velocity at the specific 
site has revolutionized the examination of arteries 
and veins. An era of noninvasive xamination has 
begun owing to the contribution of D. E. Strand- 
ness, incoming president of the American Venous 
Forum, and his colleagues at the University of Wash- 
ington, Seattle. 
In the 1960s, one technique that deserves special 
mention is the 1-125 fibrinogen uptake in the detec- 
tion of venous thrombosis. Although the technique 
is no longer in use because of the possibility of viral 
hepatitis transmission, the 1-125 fibrinogen uptake 
added significant information to our understanding 
of the natural history of venous thrombosis, espe- 
cially after surgery. The principle of radioisotope 
technique was first conceived by Mr. John Hobbs, 
with whom I had the opportunity to work closely at 
St. Mary's Hospital. 36 The I-i25 fibrinogen tech- 
nique paved the way for the development ofvarious 
preventive measures for postoperative deep vein 
thrombosis. 
In 1972, I returned to the States and joined John 
Bergan at Northwestern University Medical School, 
and we began to establish aBlood Flow Laboratory 
for clinical use. Venous thrombosis common, and 
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Fig. 2. The Keller method of extirpation ofvein by pass- 
ing the twisted wire intraluminally for extraction. (From 
Keller WL. A new method of extirpating the internal sa- 
phenous and similar veins in varicose condition. New York 
Medical 1905;82:385. Reprinted with permission from 
Ochsner A, Mahorner H. Varicose veins. St. Louis: C. V. 
Mosby Co., 1939:29.) 
the first patient with deep vein thrombosis was re- 
corded in 1515.37 The diagnosis of deep vein throm- 
bosis by clinical examination, however, is not always 
reliable. It soon became apparent that an objective 
diagnostic test was needed. At that time, both im- 
pedance plethysmography and phleborheography 
emerged as useful diagnostic techniques. We then 
began to use impedance plethysmography combined 
with continuous-wave Doppler ultrasound as astan- 
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dard noninvasive test in patients in whom deep vein 
thrombosis was suspected. The indirect technique 
lost its appeal when the B-mode scan was introduced. 
Compression ultrasonography and, thereafter, the 
color flow imager became the standard iagnostic 
test. The duplex scan also provides abetter technique 
to quantitate venous reflux. Also, the venous flow 
direction and velocity at specific anatomical sites can 
be recorded accurately. We also developed venous 
refilling time using photoplethysmography as a 
screening test for chronic venous insufficiency. 38At 
present, air plethysmography provides a more objec- 
tive measurement of venous outflow and calf-pump 
function in these patients. For varicose veins, routine 
use of duplex scanning before surgery remains uncer- 
tain because of the lack of objective studies to firmly 
establish the validity of routine use. However, there 
is no doubt that the technique is more reliable than 
the hand-held Doppler, particularly in the assessment 
of the saphenopopliteal junction. In recurrent vari- 
ces, duplex scanning is the most reliable investiga- 
tion. Duplex scanning is also helpful to resolve the 
complex anatomy of the popliteal fossa and in pa- 
tients who have short saphenous vein or gastrocne- 
mius vein incompetence. In patients who have ve- 
nous ulceration, duplex scanning is as reliable as 
phlebography in demonstrating the status of the 
deep veins, and it identifies a subset of patients who 
may benefit from vein stripping. 
In 1976, we held the first Northwestern sympo- 
sium on vascular disease on the topic of Venous 
Problems. The symposium was dedicated to Dr. 
Geza de Takats, a well-known Chicago vascular sur- 
geon. At that time, low-dose heparin was just being 
introduced as a prophylactic measure for deep vein 
thrombosis. Interestingly, asearly as 1960, Dr. Geza 
de Takats was the first investigator to suggest he 
principle of low-dose heparin. 39 At the same time, 
surgical prevention of pulmonary embolism was also 
undergoing a rapid evolution. Initial procedures 
such as intraluminal sutures or ligation have given 
way to extracaval c ips, umbrella, then filter. Further 
refinement of technology has allowed the placement 
of the filter percutaneously and has greatly simplified 
the technique of vena cava interruption. The past 
three decades have also seen a great advance in our 
understanding of hematologic risk factors in deep 
vein thrombosis. Hematologic risk factors that have 
been found to cause venous thrombosis nclude defi- 
ciency of antithrombin III, protein C or S, the an- 
tiphospholipid syndrome, and the recent identifica- 
tion of activated protein C resistance, an autosomal 
inherited condition caused by a genetic defect, usu- 
ally in factor V molecule. These tests should be 
sought in young patients who have deep vein throm- 
bosis. We also know that superficial thrombophlebi- 
tis, often considered a benign condition, may be a 
marker for a hypercoagulable state, g° Of the Virchow 
triad in venous thrombosis--staffs, endothelial dam- 
age, and coagulability--the endothelial injury has 
received little attention. Recently, Wakefield et 
al. 41,42 have found significant inflammatory esponse 
in the vein wall in venous thrombosis. They sug- 
gested that cell interactions involving neutrophils, 
monocytes/macrophages, and various kinds of cyto- 
kines may play an important role in the pathogenesis 
of venous thrombosis. The pharmacologic treatment 
of deep vein thrombosis has undergone gradual evo- 
lution since Crafoord et al.g3,44 introduced heparin 
for treannent and prevention of deep vein thrombo- 
sis. Various dose regimens in conjunction with aspi- 
rin or warfarin have been suggested. The introduc- 
tion of low-molecular weight heparin has great 
appeal because laboratory monitoring and dose ad- 
justment are no longer needed. Low-molecular 
weight heparin can be used safely for outpatient 
treatment of deep vein thrombosis. 45This is of par- 
ticular appeal in the managed care environment be- 
cause reduction of hospital stay can be achieved 
safely. 
From 1976 on, the Division of Vascular Surgery 
at Northwestern has continued the mission in post- 
graduate ducation by holding a 21/2-day symposium 
every December. In 1984 and then in 1990, we 
sponsored symposia on "Surgery of the Veins" and 
"Venous Disorders," respectively. Experts in their 
own field were invited to provide an in-depth presen- 
tation of various venous problems. We also published 
a book to accompany each meeting. This task af- 
forded me a unique opportunity to keep pace with 
developments in various aspects of venous disorders. 
No one in vascular surgery is spared the exposure 
to venous ulcer. This ancient disease was first men- 
tioned by Hippocrates (460-377 BC) .  46 In 1676, 
Richard Wiseman, Sergeant Surgeon to Charles II, 
coined the term "varicose ulcer" and described a 
laced stocking for compression treatment (Fig. 3). 47 
A leg ulcer caused by a perforating vein was first 
diagnosed by John Gay in 1868. gs He described the 
perforating veins of the calf and anlde, recorde'd the 
fact that ulcers could occur in the absence of varicose 
veins if there had been postthrombotic damage to 
the deep veins, and introduced the term "venous 
ulcer." In 1916, John Homans first popularized the 
concept of ulcers as those associated with varicose 
veins of the leg, easily cured by removal of these 
J 'OURNAL OF VASCULAR SURGERY 
Volume 26, Number 5 Yao 731 
veins, and as postthrombotic ulcers as always intrac- 
table to treatment.18 Since then, venous ulcer contin- 
ues to be a challenging problem for surgeons. At 
present, there is no breakthrough for treatment of 
venous ulcer, and gradient compression therapy pio- 
neered by Conrad Jobst remains the mainstay of 
treatment. 49Surprisingly, Unna paste, introduced in 
1893, is highly effective in healing venous ulcer, s° 
Subfascial ligation of perforating veins, introduced 
by Linton in 1938, 51 the modification of Linton's 
operation by Dodd, 52 and Rob's procedure 53 have 
only historical value. Most surgeons now favor com- 
pression treatment. Whether the new technique us- 
ing endoscopy-assisted p rforator ligation will make 
a difference awaits the conclusion of a multicenter 
trial being conducted by Dr. Peter Gloviczki. Other 
than reflux from incompetent perforating veins, we 
know very little about the pathogenesis of ulcer for- 
marion. In 1982, Browse and Burnand proposed 
that oxygen diffusion into the tissues of the skin was 
restricted by a pericapillary fibrin cuff that they had 
observed. 54 The fibrin deposited around the capillary 
forms a barrier to the passage of oxygen and other 
nutrients that sustain the cells of the epidermis. This 
leads directly to cell death and ulceration. The white 
cell theory originated with Coleridge Smith and 
Scurr.5~ They suggested that white cell sequestration 
(trapping) may cause degradation of tissues. Adhe- 
sion of white cells to endothelium, activation ofneu- 
trophils, and release of free radicals all cause tissue 
damage. In liposcleroric skin, they found significant 
increase of white cells. The "trap" hypothesis was 
suggested by Falanga and Eaglstein of Miami Uni-' 
versity. 56 This was based on the assumption that 
macromolecules l aking into the dermis as a result of 
venous hypertension bind or "trap" growth factors 
and matrix material, which then become unavailable 
for tissue repair and for the maintenance of tissue 
integrity. All of these theories point toward the need 
for a molecular biologic approach to study venous 
ulcer formation. Of interest in the treatment of ve- 
nous ulcer is the renewed attention to identifying 
varicose veins as the contributing factor. Several re- 
ports have mentioned the use of duplex scanning or 
refilling rime to identify this group ofpar ientsS ,58 
Unlike arterial bypass grafting for arterial occlu- 
sive disease, bypass grafting for venous occlusion 
continues to be a surgical challenge. Development of
venous bypass grafting started with Warren and 
Thayer s9 in 1954 on the use of saphenous vein for 
bypassing a postthrombotic o clusion of the superfi- 
cial vein, and the operation was further developed by 
Husni 6° in 1970 and May 61 in 1972. Iliac vein occlu- 
i 
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Fig. 3. Laced-up leather stocking developed by Richard 
Wiseman for compression treatment ofvenous ulcer. (Re- 
printed with permission from Bergan JJ. Historical high- 
lights in teaching venous insufficiency. In: Bergan JJ, Yao 
JST. Venous disorders. Philadelphia: W. B. Saunders, 
1991:8.) 
sion was first similarly treated by femorofemoral by- 
pass by Palma et al.62 in 1958. The technique was 
further popularized by Dale 63 and Halliday et al. 64 In 
recent years, polytetrafluoroethylene grafts have 
been used for femorofemoral crossover grafting with 
simultaneous reconstruction of an arteriovenous fi - 
tula to maintain graft patency. 65 The fistula is then 
ligated several months later. Maintaining patency of 
venous bypass grafts is often difficult because of the 
low flow rate of venous flow and, possibly, hemato- 
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Fig. 4. Valves of a leg vein first described by Aquapen- 
dente. (Reprinted with permission from Gottlob R, May 
R. Venous valves. Vienna: Springer-Verlag, 1986:5.) 
logic factors that predispose the graft to thrombosis. 
In acute venous thrombosis, thrombectomy has 
nearly become xtinct from the surgical scene in this 
country. However, some European colleagues have 
claimed success in restoring flow in acute iliac vein 
thrombosis by combining thrombectomy with an 
arteriovenous fistula. 66 In our vascular service, we 
have used vein bypass grafting for thrombotic occlu- 
sion only in selected instances. Another frequent use 
of bypass grafting is in patients who have nonthrom- 
boric conditions. These indude panel grafting for pop- 
liteal venous aneurysm resection, 67spiral grafting for 
superior vena cava syndrome, 6sand brachial vein graft- 
ing for patients who have hemodialysis arteriovenous 
fistula with subclavian thrombosis and in patients who 
have thoracic outlet compression syndrome. 
One of the most intriguing developments to oc- 
cur in venous surgery in the past three decades is 
venous valve repair. According to Franldin, 69 Gian 
Battisa Canano, professor of anatomy at Ferrara, was 
the first to identify venous valve in the azygous vein 
and renal vein. Venous valve in leg veins was de- 
scribed in detail by Aquapendente (1537-1619), a
teacher of anatomy at the University of Padua (Fig. 
4). 7° William Harvey in 1628 first observed and de- 
scribed the function of  venous valve that led to his 
discovery of the unidirectional flow of  blood circula- 
tion. 71 An attempt to correct venous valve incompe- 
tence experimentally was made by Eiseman et al. in 
1953. 72 In 1975, Kistner first described venous valve 
repair in human beings. 73 Since then, venous valvu- 
loplasty, transposition, or transplantation have been 
introduced. Newer techniques such as implantation 
of cryopreserved valve or endoscopy-assisted valve 
repair are within reach for clinical trial. Whether 
correction of a single valve incompetency will be 
sufficient o reverse the course of chronic venous 
insufficiency, however, remains to be seen. In our 
limited experience, we found that correction f the 
femoral valve alone yielded disappointing results. 74 
Nevertheless, we are now in an exciting stage to 
correct venous reflux in patients with chronic venous 
insufficiency. 
In recent years, interventional technology has 
emerged as an alternate method in the treatment of 
venous disorders. In addition to percutaneous place- 
ment of vena cava filter and endoscopic ligation of 
perforator veins, several new treatment methods uch 
as urokinase infusion and balloon dilatation with or 
without stent placement are available to treat venous 
stenosis. 75 The incidence of subclavian vdin throm- 
bosis has increased as a result of the frequent use of 
indwelling catheters for hyperalimentation or che- 
motherapy, and in some patients thrombosis even 
progressed to develop the superior vena caval syn- 
drome. At present, uroldnase infusion is highly effec- 
tive in treating acute subclavian-axillary vein throm- 
bosis. The advantage of this approach in effort 
thrombosis i to uncover the underlying pathologic 
mechanism, which allows a plan for future correction 
of the anomaly. Compression is often caused by the 
clavicle head, which makes surgical correction diffi- 
cult. Even with stent placement in the stenotic le- 
sion, recurrent thrombosis i common because of the 
mobility of the thoracic outlet and also the clavicle 
head. In superior vena cava occlusion, disobliteration 
by uroldnase followed by balloon dilatation and stent 
placement has been successful in providing symp- 
tomatic relief in these patients. 76 In massive swollen 
leg as a result ofvena cava thrombosis, we also found 
that urokinase treatment--by placing a catheter in 
the popliteal vein for selective infusion--followed by 
stent placement restored patency of major veins in 
JOURNAL OF VASCULAR SURGERY 
Volume 26, Number 5 Yao 733 
these patients. Endovascular stents have also been 
placed in iliac vein compression, better known as the 
May and Turner syndrome. 77 The idea is intriguing; 
however, a large series is needed to further substan- 
tiate the validity of this form of interventional ther- 
apy. Other interventional techniques we use together 
with radiologists include alcohol injection to reduce 
the size of venous malformation and to occlude the 
incompetent ovarian vein with coils in patients who 
have peMc congestion syndrome. 7s
One of most significant developments in the field 
of venous disorders was the formation of the Ameri- 
can Venous Forum. The organization was formed in 
1986 with the mission to promote research and edu- 
cation in 'venous disease. Certainly, venous disorders 
have been neglected, not only in the teaching curric- 
ulum but also in the priority of research and educa- 
tion in most of the vascular surgical training pro- 
grams. Since the inception of" this organization, 
significant steps have been taken to accomplish the 
objectives set out by the founding members. We now 
have a Foundation to support research efforts. Sev- 
eral rewards, including a research fellowship, are now 
in place. The annual meeting allows a meaningful 
exchange and dissemination of knowledge. The ad- 
ditional postgraduate course is designed to focus on 
current venous problems. For clinical practice, vari- 
ous committees have been formed to look into issues 
related to reimbursement and terminology for classi- 
fication of venous disorders. A report on research 
plans in venous disease has been completed by the 
research committee, and this document will serve as 
the blueprint for future direction in venous research. 
The American Venous Forum has produced a con- 
sensus statement on classification of chronic venous 
insufficiency, the reporting standard on venous dis- 
ease with the joint vascular societies, and a handbook 
on venous disorders. For promotion of research, a
dialogue has been established with leaders of 
NHLBI /N IH  to develop joint research programs in 
venous research. Although we have been quite suc- 
cessful, it is important o remind ourselves that the 
American Venous Forum is not a social club and its 
mission is to promote research and education in 
venous disorders. To achieve this aim, we need to 
define our target audience. If  our mission is to edu- 
cate vascular surgeons, we need to take steps to reach 
the younger generation of trainees in vascular sur- 
gery and to work with the Association of Program 
Directors in Vascular Surgery to develop curricula to 
enhance education in venous disease. We need to 
give strong consideration to rescheduling this meet- 
ing to be in conjunction with the annual meeting of 
the Society for Vascular Surgery and the Interna- 
tional Society for Cardiovascular Surgery. As we all 
know, veins run parallel with arteries, and we are part 
of the main of vascular surgery. I have no doubt that 
cross-fertilization is certainly better than isolation. 
We need to build bridges with other disciplines to 
move the field forward. Vascular surgery has changed 
a great deal as a result of technical innovations, and 
we need to work with radiology colleagues to bring 
new techniques to treat this disorder. There have 
been significant changes in the care of patients with 
venous problems in the past three decades, and we 
need to continue to make changes. Change is desir- 
able and change is for life. I thank the members for 
the opportunity to serve as your president and I am 
confident hat the incoming president, Dr. Eugene 
Strandness, will make veins get more respect and, 
more important, will work to fulfill the mission of the 
American Venous Forum. 
REFERENCES 
1. Ochsner A. Venous thrombosis. Surgery 1948;24:445-51. 
2. Allen AW. The present evaluation of the prophylaxis and 
treatment of venous thrombosis and pulmonary embolism. 
Surgery 1949;26:1-7. 
3. Veal JR, Cotsonas NJ Jr. Diseases of the superior vena caval 
system with special consideration ofpathology and diagnosis. 
Surgery 1952;31:1-12. 
4. Pravaz. Corn Rend Acad de Sc Paris. 1851;36:88. 
5. Chassaignac; quoted by Babcock WW. A textbook of surgery. 
2nd ed. Philadelphia: W. B. Saunders, 1936. 
6. McPheeters HO. Varicose veins: with special reference to the 
injection treatment. Philadelphia: F. A. Davis Co., 1931. 
7. Villavicencio IL, Pfeifer JR, Lohr JM, Goldman MP, Cranley 
R, Spence R, et al. Sclerotherapy for varicose veins: practice 
guidelines and sclerotherapy rocedures. In: Gloviczki P, Yao 
JST, editors. Handbook of venous disorders. London: Chap- 
man & Hall Medical, p. 337-54. 
8. Laufman H. The veins. Austin, Tex: Silvergirl, Inc., 1986. 
9. Ochsner A, Mahomer H. Varicose veins. St. Louis: C.V. 
Mosby Co., 1939. 
10. Scott HJ. History of venous disease and early management. 
Phlebology 1992;Suppl. 1:2-5. 
11. Davat. Du traitement curatif des varices. J d conn med Prat, 
Par, 1837-1838;5:69-72,102-4. 
12. Madelung H. Uber die ausschalung cirsoider Varicen an den 
unteren Extremitaten. Verhandl Deutsch Gesellsch Chir 
I884;13:114-7. 
13. Trendelenburg F. Uber die unterbindung der vena saphena 
magna bei unterschenkelvaricen. Beitrage zur Klinischen 
Chirurgie i890;7:195~210. 
14. Keller WL. A new method of extirpating the internal saphe- 
nous and similar veins in varicose condition. New York Med- 
ical 1905;82:385-6. 
15. Mayo CH. Treatment of varicose veins. Surg Gynecol Obstet 
1906;2:385-8. 
16. Babcock WW. A new operation for extirpation of varicose 
veins of the leg. N Y Med J 1907;86:153-6. 
JOURNAL OF VASCULAR SURGERY 
734 Yao November 1997 
17. Tavel E. Die Behandlung der Varicen durch die kunstliche 
Thrombose. Deutsche Atschr Chir 1912;116:735. 
18. Homans J. The operative treatment of varicose veins and 
ulcers, based upon a classification of these lesions. Surg Gy- 
necol Obstet 1916;22:i43-58. 
19. Satin S, Scurr JH, Coleridge Smith PD. Stripping of the long 
saplxenous vein in the treatment ofprimary varicose veins. Br J 
Surg 1994;81:1455-8. 
20. Bergan JJ. Saphenous vein stripping and quality of outcome. 
Br J Surg 1996;83:1025-7. 
21. Darke SG. The morphology of recurrent varicose veins. Eur J 
Vasc Surg 1992;6:512-7. 
22. Tibbs DT. Varicose veins. In: Morris PJ, Malt RA, editors. 
Oxford textbook of surgery. Oxford, U.K.: Oxford University 
Press, 1994:551. 
23. Rucldey CV. Operations for varicose veins. In: Jamieson CW, 
Yao JST, editors. Vascular surgery. 5th ed. London: Chap- 
man and Hall Medical, 1994:552-7. 
24. DeTakats G. Ambulatory ligation of the saphenous vein. 
JAMA 1930;94:1194-7. 
25. Hobbs JT. A new approach to short saphenous vein varicosi- 
ties. In: Bergan JJ, Yao JST, editors. Surgery of the veins. 
Orlando, Fla.: Grune & Stratton, Inc., 1985:301-22. 
26. Hobbs IT. The enigma of the gastrocnemius vein. Phle- 
bology 1988;3:19-30. 
27. McCarthy WI, Dann C, Pearce WH, Yao JST. Management 
of sudden profuse bleeding from varicose veins. Surgery 
1993;113:178-83. 
28. Callam MJ. Epidemiology of varicose veins. Br J Surg 1994; 
81:167-73. 
29. Abenhaim L, Kurz X, Norgren L, Clement D. The manage- 
ment of chronic venous disorders of the leg (CVDL): an 
evidence-based report of an international task force. Mon- 
treal: McGill University, 1995. 
30. Perrot-Applanat M, Cohen-Solal K, Milgrom E, Finet M. 
Progesteron receptor expression in human saphenous veins. 
Circulation 1995;92:2975-83. 
31. Hayer M, Caporiccio A, Pages A, Caporiccio G, Toueri MF, 
Magnan de Bamier B. Lysosomal enzymes and severity of sa- 
phen vaticosis. Clin China Acta 1991;203:343-8. 
32. Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith 
PD. Plasma elastase in venous disease. Br J Surg 1994;81: 
1496-9. 
33. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare 
RJ, Tilson MD.-Analysis of the connective tissue matrix and 
proteolytic activity of primary varicose veins. J Vasc Surg 
1993;18:814-20. 
34. Wolfe JHN, Morland M, Browse NL. The flrbrinolytic activ- 
ity of varicose veins. Br J Surg 1979;66:185-7. 
35. Shireman PK, McCarthy WJ, Pearce WH, Shively VP, Cipol- 
lone M, Kwan HC, Yao JST. Plasminogen activator levels are 
influenced by location and varicosity in greater saphenous 
vein. J Vasc Surg 1996;24:719-24. 
36. Hobbs JT, Davies JWL. Detection of venous thrombosis with 
~alI-labelled fibrinogen in the rabbit. Lancet 1960;2:134- 5.
37. Dexter L, Folch-Pi W. Venous thrombosis: an account of the 
first documented case. JAMA 1974;228:195-6. 
38. Abramowitz HB, Queral LA, Flinn WR, Nora PF Jr, Peterson 
LK, Bergan JJ. The use of photoplethysmography in the 
assessment of venous insufficiency: a comparison to venous 
pressure measurments. Surgery 1979;86:434-41. 
39. de Takats G. Anticoagulant in surgery. JAMA 1950;142:527- 
33. 
40. Ascer E, Hanson JN, DePippo P, Lorensen E. Superficial vein 
thrombophlebitis: a marker of hypercoagulability? Presented 
at the 50th Annual Meeting of The Society for Vascular 
Surgery, Chicago, Ill., June 11-12, 1996. 
41. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski 
SK, Burdick MO, et al. Venous thrombosis-associated inflam- 
mation and attenuation with neutralizing antibodies to cyto- 
kines and adhesion molecules. Arterioscler Thromb Vasc Biol 
1995;15:258-68. 
42. Wakefield TW, Strieter RM, Downing LJ, Kadell AM, W'flke 
CA, Burdick MD, et al. P-selectin and TNF inhibition reduce 
venous thrombosis nflammation. J Surg Res 1996;64:26-31. 
43. Crafoord C. Heparin and postoperative thrombosis. Acta 
Chit Scand 1939;82:319-35. 
44. Crafoord C, Jorges JF. Heparin as a prophylactic against 
thrombosis. JAMA 1941;116:2831-5 
45. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J. 
A comparison of low-molecular-weight heparin adminstered 
primarily at home with unfractional heparin administered in
the hospital for proximal deep-vein thrombosis. N Engl 
J Med 1996;334:677-81. 
46. Hippocrates. The genuine works of Hippocrates [Adams EF, 
trans.], vol. 2. New York: Wm. Wood & Co, 1866:305. 
47. Wiseman R. SeveraU chirurgical treatises. London: Rogston 
& Took, 1676. 
48. Gay J. Varicose disease of lower extremities and its allied 
disorders. Lettsomian Lecturer of 1867. London: Churchill, 
1868. 
49. Schad F. Conrad Jobst. Columbus, Ohio: M.E. Media Words 
& Pictures Inc., 1979. 
50. Laufman H. Selections from the dermatological writings of 
Dr. P.G. Unna, The New Sydenham Society, 1893. In: Lauf- 
man H. The veins. Austin, Tex.: Silvergirl, Inc., 1986. 
51. Linton RR. The communicating veins of the lower leg and 
the operative technique for their ligation. Ann Surg 1938; 
107:582-93. 
52. Dodd H. The diagnosis and ligation of incompetent perforat- 
ing veins. Ann Royal Coll Surg Engl 1964;34:186-96. 
53. Rob C. Surgery of the vascular system. Minneapolis: Univer- 
sity of Minnesota, 1972:267. 
54. Browse NL, Burnand KG. The cause of venous ulceration. 
Lancet 1982;2:243-5. 
55. Coleridge Smith PD, Scurr JH. Current views on the patho- 
genesis of venous ulceration. In: Bergan JJ, Yao JST, editors. 
Venous disorders. Philadelphia: W. B. Saunders Co., 1991: 
36-54. 
56. Falanga V, Eaglstein WH. The "trap" hypothesis of venous 
ulceration. Lancet 1993;341:1006-7. 
57. Grabs AJ, Wakely MC, Nyamekye I, Ghauri ASK, Poskitt KR. 
Color duplex ultrasonography in the rational management of 
chronic venous leg ulcers. Br J Surg 1996;83:1380-2. 
58. Coleridge Smith PD. Impact of duplex ultrasound scanning 
in varicose vein surgery. In: Yao JST, Pearce WH, editors. 
Progress in vascular surgery. Stamford, Conn.: Appleton & 
Lange, 1997:523-33. 
59. Warren R, Thayer T. Transplantation f the saphenous vein 
for post-phlebitic stasis. Surgery 1954;35:867-76. 
60. Husni EA. Clinical experience with femoropopliteal ve- 
nous reconstruction. In: Bergan JJ, Yao JST, editors. Ve- 
nous problems. Chicago: Year Book Medical Publishing, 
1978:485-92. 
61. May~ IL Der Femoralisbypass beim postthrombotischen 
Zustandsbild. Vasa 1972;1:267. 
62. Palma EC, Esperon R. Vein transplants and grafts in the 
surgical treatment of the postphletitic syndrome. J Cardiovasc 
Surg (Torino) 1960;1:94-107. 
JOURNAL OF VASCULAR SURGERY 
Volume 26, Number 5 Yao 735 
63. DaleWA. Crossover vein grafts for reliefofiliofemoralvenous 
block. Surgery 1965;57:608-12. 
64. Halliday P, Harris J, May J. Femorofemoral crossover grafts 
(Palma operation): a long-term follow-up study. In: Bergan 
JJ, Yao JST, editors. Surgery of the veins. Orlando, Fla.: 
Grune & Stratton, 1985:241-54. 
65. Gruss JD. Venous bypass for chronic venous insufficiency. In: 
Bergan JJ, Yao JST, editors. Venous disorders. Philadelphia: 
W. B. Saunders, 1991:316-32. 
66. EkhofB, Juhan C, Neglen P. Iliofemoral thrombectomy and 
temporary arteriovenous fi tula. In: Bergan JJ, Kistuer RL, 
editors. Atlas of venous surgery. Philadelphia: W. B. Saun- 
ders, 1992:223-31. 
67. Winchester DJ, Pearce WH, McCarthy WJ, McGee GS, Yao 
JST. Popliteai venous aneurysms. Surgery 1993;114:600-7. 
68. Yao JST, Pearce WH, McCarthy WJ. Reconstructive nous 
surgery. In: Bergan JJ, Yao JST, editors. Venous disorders. 
W.B. Saunders, 1991:306-15. 
69. Franklin KI. A monograph on veins. Springfield, Ill.: Charles 
C. Thomas, 1937. 
70. Gottlob R, May R. Venous valves. Vienna: Springer-Verlag, 
1986. 
71. Harvey W. An anatomical decscription concerning the move- 
ment of the heart and blood in living creatures [Whitteridge G, 
trans.] Oxford, U.K.: Blackwell Scientific Publications, 1976. 
72. Eiseman B, Malette W. An operative technique for the con- 
struction of venous valves. Surg Gynecol Obstet 1953;97: 
731-4. 
73. Kistner RL. Surgical repair of the incompetent femoral vein 
valve. Arch Surg 1975;110:1336-42. 
74. Johnson ND, Queral LA, Flinn WR, Yao JST, Bergan JJ. Late 
objective assessment ofvenous valve surgery. Arch Surg 1981; 
116:1461-6. 
75. Antonucci F, Salamonowitz E, Stuckmann G, et al. Place- 
ment of venous tents: clinical experience with a self-expand- 
ing prosthesis. Radiology 1992;183:493-7. 
76. Vogelzang RL. Endovascular metallic stents for treatment of 
superior vena cava syndrome. In: Yao JST, Pearce WH, edi- 
tors. Progress in vascular surgery. Stamford, Conn.: Appleton 
& Lange, 1997:515-23. 
77. Nazarian GK, Bjarnason H, Dietz CA Jr, Bernadas CA, 
Hunter DW. Iliofemoral venous stenoses: effectiveness of 
treatment with metallic endovascular stents. Radiology 1996; 
200:193-9. 
78. Sichlau MJ, Yao JST, Vogelzang RL. Transcatheter mbolo- 
therapy for the treatment of pelvic congestion syndrome. 
Obstet Gynecol 1994;83:892-6. 
Submitted Feb. 24, 1997; accepted Feb. 28, 1997. 
